Mini ReviewPublished 7 October 2026Pan-cancer biomarkers of immune therapy resistance: mechanisms and clinical translationChao Wang · Dong YangFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1895670
Mini ReviewPublished 5 October 2026TRIM22 in cancer: a context-dependent E3 ligase at the interface of interferon, p53, and tumor plasticityChenjie Qiu · Liangliang DaiFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1977247
EditorialPublished 30 September 2026Editorial: Cancer biomarkers: molecular insights into diagnosis, prognosis, and risk prediction: volume IIMatteo Becatti · Giuseppe Bronte · Shaoquan ZhengFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1999668
Original ResearchPublished 26 June 2026Arsenic induced Hippo pathway dysregulation linked to hTERT hypo-methylation in breast cancer patientsArchana Chaudhary · Manish Kumar · Lalit Mohan · Abhay Kumar · Rishikesh Kumar · Shailesh Kumar · Kumar Pranay · Nandani Kumari · Rizwanul Haque · Md. Margoob AhmadFrontiers in Epigenetics and Epigenomicsdoi 10.3389/freae.2026.1853054
ReviewPublished 8 May 2026Advancements in cancer biomarker discovery over fifteen years: diagnostics and prognostic approach in somatic cancerMohd Basheeruddin · Sana Qausain · Ashish Anjankar · Faez Iqbal KhanOncology Reviewsdoi 10.3389/or.2026.1809836
Original ResearchPublished 29 April 2026Thiol-mediated electrochemical sensor for the breast cancer biomarker CA 15-3Nastaran Ghaffari · Priscilla BakerFrontiers in Sensorsdoi 10.3389/fsens.2026.1807434
